Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
USE OF RILUZOLE, RILUZOLE PRODRUGS OR RILUZOLE ANALOGS WITH IMMUNOTHERAPIES TO TREAT CANCERS
No-Receipt date
2024-01628 - 29/04/2024
No-Filing date
20240401020 - 29/04/2024
No-Granting date
3115319 - 15/05/2024
No-EPO application date
21207246.6 - 19/05/2017
No-EPO granting date
4019019 - 07/02/2024
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
5/2024 - 11/06/2024
Expiration date
20/05/2037
Kind of title
Validation of European Patent
Legal status
VALID
Priorities
US201662339433 P20/05/2016/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 31/428
A61P 35/00
C07D 277/82
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
1607612
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
215 CHURCH STREET
NEW HAVEN, CT 06510
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
4188646
CORIC, VLADIMIR
Representatives
Code
Firstname
Surname
Address
Town
Zip
3712
ANTHOULA
GALANOPOULOU
THESI LYSI MPITAKOU
KAPANDRITI (ATTIKIS)
19014
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
9219
ALKISTIS-EIRINI
MALAMI
VISSARIONOS 3
ATHINA (ATTIKIS)
10672
GREECE
Owners History
Title Instruments
Payments history
9 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).